OsteoarthitisTapingNCT07606157
Effects of Kinesiotaping in Osteoarthritis
A study testing Kinesiotaping in people with Osteoarthitis, run by Nazli Cigercioglu.
Trial summary
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain… Read more about this study
- Who is it for?
- Ages 40 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Osteoarthitis
- What is being tested?
- Kinesiotaping
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- 20 Jun 2026to 20 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Diagnosis of unilateral grade 2 knee osteoarthritis,
- Age between 40 and 65 years,
- Ability to understand and comply with assessments and interventions,
- Independent ambulation without assistive devices,
- No participation in a physiotherapy program for knee-related complaints within the previous year
Who cannot join
- History of lower extremity surgery or trauma,
- Presence of neurological or orthopedic conditions affecting gait or physical function,
- Allergic reaction to kinesiotape,
- Inability to walk independently.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
Nazli Assoc. Prof. Nazli Cigercioglu, Assoc. Prof. contact
About this study
Official title: Effects of Adding Kinesiotaping to Conventional Physiotherapy on Pain, Function, and Kinesiophobia in Knee Osteoarthritis: A Randomized Controlled Trial
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.
This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.
A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.
Read the detailed description
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.
This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.
A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.
- Conditions
- Osteoarthitis
- Being tested
- Kinesiotaping
- Keywords
- osteoarthritis, physiotherapy
- Medical subject headings
- Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KinesiotapingOther
Kinesiotaping
| Study group | Role | What they receive |
|---|---|---|
| Kinesiotaping | Experimental | Kinesiotaping Receives: Other: Kinesiotaping |
What is being measured
The primary outcome is the main question the study is designed to answer.
Kinesiophobia
Kinesiophobia will evaluated using the Tampa Scale of Kinesiophobia (TSK) and the Fear-Avoidance Beliefs Questionnaire (FABQ). The TSK is a 17-item questionnaire scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), with total scores ranging from 17 to 68, where higher scores indicate greater fear of movement. The FABQ assesses fear-avoidance beliefs related to physical activity and has been widely used in musculoskeletal disorders.
Measured: 4 weeks
Secondary outcomes (4)
Pain intensity
Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from "no pain" (0) to "worst imaginable pain" . Participants will be asked to indicate the intensity of their knee pain during activity, and the marked distance will be measured in centimeters
Measured: 4 weeks
Functional status
Functional status will be assessed using performance-based tests. The 30-Second Sit-to-Stand Test will be used to evaluate lower extremity muscle strength and endurance. Participants will be instructed to stand up and sit down as many times as possible within 30 seconds, and the total number of repetitions will be recorded .
Measured: 4 weeks
Functional mobility
The 12-Step Stair Climb Test will be used to assess functional mobility and lower limb performance. Participants will be asked to ascend and descend a 12-step staircase as quickly and safely as possible, and the total time taken to complete the task will be recorded in seconds .
Measured: 4 weeks
Dynamic balance
Dynamic balance will be evaluated using the Functional Reach Test. Participants will be instructed to stand upright and reach forward as far as possible without losing balance or taking a step. The maximum distance reached will be measured in centimeters .
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2026
- Study start20 Jun 2026 (estimated)
- Primary completion20 Dec 2026 (estimated)
- Study completion20 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OsteoarthitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Sequential
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Nazli Cigercioglu
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Nazli Cigercioglu, Hacettepe University
- Investigators
- Cigercioglu, Principal investigator, Hacettepe University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07606157
- Sponsor's protocol ID
- OA_RCS_2026
- Acronym
- Taping
- Status last verified
- May 2026
- First submitted
- 7 May 2026
- Last updated
- 26 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: It will be provided upon request if deemed necessary.
Study at a glance
From the registry record, last updated by the sponsor on 26 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Adding Kinesiotaping to Conventional Physiotherapy on Pain, Function, and Kinesiophobia in Knee Osteoarthritis: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07606157
- Acronym / sponsor ID
- Taping / OA_RCS_2026
- Conditions
- Osteoarthitis
- Keywords
- osteoarthritis, physiotherapy
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Nazli CigerciogluUniversity, hospital or other
- Study start
- 20 Jun 2026 (estimated)
- Primary completion
- 20 Dec 2026 (estimated)
- Study completion
- 20 Jun 2027 (estimated)
- First posted
- 26 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.
This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.
A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.
Detailed description
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.
This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.
A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Kinesiotaping | Experimental | Other: KinesiotapingKinesiotaping |
Who may qualify
- Ages
- 40 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Diagnosis of unilateral grade 2 knee osteoarthritis,
- Age between 40 and 65 years,
- Ability to understand and comply with assessments and interventions,
- Independent ambulation without assistive devices,
- No participation in a physiotherapy program for knee-related complaints within the previous year
Key exclusion criteria (4 listed)
- History of lower extremity surgery or trauma,
- Presence of neurological or orthopedic conditions affecting gait or physical function,
- Allergic reaction to kinesiotape,
- Inability to walk independently.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KinesiotapingKinesiotaping | Other | Kinesiotaping |
Primary outcome
Kinesiophobia
Time frame: 4 weeks
Kinesiophobia will evaluated using the Tampa Scale of Kinesiophobia (TSK) and the Fear-Avoidance Beliefs Questionnaire (FABQ). The TSK is a 17-item questionnaire scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), with total scores ranging from 17 to 68, where higher scores indicate greater fear of movement. The FABQ assesses fear-avoidance beliefs related to physical activity and has been widely used in musculoskeletal disorders.
4 secondary outcomes
Pain intensity
Time frame: 4 weeks
Functional status
Time frame: 4 weeks
Functional mobility
Time frame: 4 weeks
Dynamic balance
Time frame: 4 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 May 2026.
- Individual participant dataSharing planned: Undecided. It will be provided upon request if deemed necessary.
Related trials for Osteoarthitis
Recruiting
Low Dose Radiotherapy for Osteoarthritis
Osteoarthitis
Recruiting
Patient Pain and Function in Medial Knee Osteoarthritis After Anteromedial vs Anterolateral Intra-Articular Corticosteroid Injection
Osteoarthitis, Osteoarthritic Knee Pain
Recruiting
Evaluating the Role of Genicular Artery Embolization in Treatment of Persistent Pain in Patients With Severe Knee Osteoarthritis
Osteoarthitis
Not yet recruitingPhase 2
CBD Knee Osteoarthritis Study
Osteoarthitis
Not yet recruitingObservational study
Biomechanical Evaluation With Finite Element Models in Thumb Carpometacarpal Osteoarthitis: Prospective Comparative Analysis of Loads in Arthroplasty With or Without Implants
Thumb Carpometacarpal Joint Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Nazli Assoc. Prof. Nazli Cigercioglu, Assoc. Prof. contact
Cigercioglu principal investigator
Hacettepe University
Questions about this trial
What is this clinical trial studying?
A study testing Kinesiotaping in people with Osteoarthitis, run by Nazli Cigercioglu.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 26 May 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Nazli Assoc. Prof. Nazli Cigercioglu, Assoc. Prof. (+90 541 290 32 93, nazlicigercioglu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Kinesiophobia (time frame: 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2026.